Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Private Foundation To Award Three $50K Grants to Mid-Atlantic Region Repurposing Research ProjectsThis private foundation Request for Proposal (RFP) is soliciting proof of concept human clinical trial repurposing research proposals in any unsolved human disease. It is geographically restricted to the Mid-Atlantic states of Maryland, Pennsylvania, Delaware, Virginia and Washington D.C., with a preference to fund institutions in D.C. or Baltimore. The foundation is primarily interested in the repurposing of generic drugs, diagnostics, nutriceuticals or devices to reduce the symptoms, progress and incident of disease, alone or in combination with current therapies. Individuals can learn more about and view this and other RFPs by registering for free as a CureAccelerator (https://app.cureaccelerator.org/ “This is a great opportunity for researchers and clinicians in the Mid-Atlantic region to receive funding for repurposing projects focused on an unsolved human disease,” said Dr. Bruce Bloom, President and Chief Science Officer at Cures Within Reach. “We are especially interested in projects that are ready for a proof of concept clinical trial supported by strong preclinical and clinical evidence and observations.” These awards are being offered at the same time that Cures Within Reach is galvanizing researchers and clinicians to post new repurposing projects and ideas to CureAccelerator during its “100 Projects in 100 Days” campaign, to show the world that creating treatments through repurposing research clinical trials is a critical way to improve healthcare outcomes and reduce healthcare costs. “We are rallying researchers and clinicians from around the world to post their repurposing proposals and ideas to CureAccelerator to help us reach our goal of 100 new projects by February 15,” said Dr. Bruce Bloom, President and Chief Science Officer at Cures Within Reach. “Using this momentum and collaboration, we can change how quickly and affordably treatments can be developed through repurposing research in 2016 and beyond.” ABOUT CURES WITHIN REACH Cures Within Reach (http://www.cureswithinreach.org) works to catalyze repurposing research to quickly and affordably improve patient lives. We accomplish this through collaborations that connect researchers and funding, by facilitating crowd sourcing and community, and by identifying alternative financing models and incentives. Cures Within Reach’s repurposing research projects have generated 12 “new” treatments making an impact in the following diseases through off-label use in clinical practice or through a commercialization track: autoimmune lymphoproliferative syndrome, familial dysautonomia, Types 1 and 2 diabetes, lung cancer, multiple sclerosis, prostate cancer, myelodysplastic syndrome and 4 additional pediatric auto-immune diseases. Cures Within Reach has a portfolio of current projects poised to make impact in Batten disease, multiple sclerosis, Parkinson’s disease, pediatric delirium, pediatric brain tumors, lung cancer, ascites, melanoma, autism, Alzheimer’s disease, prematurity, pediatric leukemia, and polycystic kidney disease. The organization built CureAccelerator (http://cureaccelerator.org) Visit us at www.cureswithinreach.org or follow us via Twitter.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|